12-120462041-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003769.3(SRSF9):c.644T>A(p.Phe215Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,611,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003769.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRSF9 | NM_003769.3 | c.644T>A | p.Phe215Tyr | missense_variant | 4/4 | ENST00000229390.8 | |
GATC | NM_176818.3 | c.*2082A>T | 3_prime_UTR_variant | 4/4 | ENST00000551765.6 | ||
GATC | NR_033684.2 | n.2628A>T | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRSF9 | ENST00000229390.8 | c.644T>A | p.Phe215Tyr | missense_variant | 4/4 | 1 | NM_003769.3 | P3 | |
GATC | ENST00000551765.6 | c.*2082A>T | 3_prime_UTR_variant | 4/4 | 1 | NM_176818.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251028Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135680
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1459450Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 726036
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | The c.644T>A (p.F215Y) alteration is located in exon 4 (coding exon 4) of the SRSF9 gene. This alteration results from a T to A substitution at nucleotide position 644, causing the phenylalanine (F) at amino acid position 215 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at